Global Oncology

When Gloria Chiniere Okwu discovered a lump in her left breast in 2016, she could not have imagined that the diagnosis would eventually make her one of the most influential patient advocates in Nigeria. Today, Gloria is a cancer survivor,…

When Martha Raymond, the Founder and CEO of the GI Cancers Alliance and the Raymond Foundation,  was seven years old, she lost her father to colon cancer. Years later, her mother's illness would change the course of her own life.…

We often describe progress in oncology through the language of discovery. Scientific breakthroughs. Technological innovation. Deeper biological insight. These advances have transformed medicine, helping millions of people live longer and better than ever before. Yet alongside every scientific breakthrough, a…

Karen Nakawala spent decades telling other people's stories. As one of Zambia's well-known broadcasters, she knew how to command a microphone, connect with audiences and give voice to people whose experiences might otherwise go unheard. Whether presenting a live radio…

Millions of cancer patients live within reach of life saving radiation treatment. Millions more live nowhere near it. The research maps just how wide, and how consequential, that gap has become. Radiotherapy is a cornerstone of modern cancer care. Around…

Over four decades, Dr Tezer Kutluk, Scientific Director of Medicana Health group and Chair of the Department of Pediatric Oncology at Medicana Hospitals, Turkey, has witnessed the transformation of cancer care—from the early days of pediatric oncology to the era…

How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…

“Tax planning was one major reason for the foundation of Elekta.” Larry Leksell says it with a smile that suggests he enjoys disrupting the mythology people create around founders. Most people expect a grand story of origin. A visionary revelation.…

We often describe progress in oncology through the language of innovation. New drugs. New technologies. New discoveries. Yet scientific breakthroughs rarely change cancer care on their own. They require people willing to pursue difficult ideas, build institutions, challenge accepted thinking,…

Five trials, five cancers, and what the ASCO 2026 plenary really promised patients ASCO 2026’s plenary delivered five real advances across five cancers, and a standing ovation that pulled a hall full of oncologists to their feet. The harder question…